Fig. 3

Graphical schematization of clinical symptoms score trends after 30 days since treatment suspension and after 30 days since treatment resumption. a Mean conjunctival inflammation scores before (T 60) and after 30 days nutraceutical diet suspension (T 90) for ND group and (b) after 30 days since nutraceutical diet resumption (T 120); c mean corneal keratinization scores before (T 60) and after 30 days nutraceutical diet suspension (T 90) for ND group and (d) after 30 days since nutraceutical diet resumption (T 120); e mean corneal pigment density scores before (T 60) and after 30 days nutraceutical diet suspension (T 90) for ND group and (f) after 30 days since nutraceutical diet resumption (T 120), scores resulted significantly increased (*P < 0.05); g mean mucus discharge scores before (T 60) and after 30 days nutraceutical diet suspension (T 90) for ND group and (h) after 30 days since nutraceutical diet resumption (T 120), scores resulted significantly increased (**P < 0.01); i mean tear production (STT) in mm/min before (T 60) and after 30 days nutraceutical diet suspension (T 90) for ND group and (l) after 30 days since nutraceutical diet resumption (T 120)